Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, announced today the first patient treated with the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE